Assessing a new approach to lung cancer screening
Feasibility Testing the Engaged Approach to Lung Cancer Screening
This study is testing a new way to screen for lung cancer to see if it works well and is accepted by different screening programs and their staff across the U.S.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Denver, Colorado) |
| Trial ID | NCT06327074 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and acceptability of the Engaged Approach to Lung Cancer Screening (EA-LCS) across various lung cancer screening programs in Colorado and the broader United States. It involves a multilevel assessment that includes both the screening programs and their staff members. The study aims to gather insights from program staff who are directly involved in lung cancer screening operations, ensuring a comprehensive understanding of the approach's effectiveness in diverse settings.
Who should consider this trial
Good fit: Ideal candidates for this study are staff members from lung cancer screening programs that conduct a minimum of 50 low-dose computed tomography scans annually.
Not a fit: Patients who are not involved in lung cancer screening programs or those who do not meet the staff member inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance lung cancer screening processes, leading to earlier detection and improved patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in enhancing screening processes, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The trial incorporates a multilevel assessment and enrollment involves inclusion criteria at two levels: (1) LCS Program and (2) LCS Program Staff member. Program inclusion criteria (n = up to 8 sites): * Must conduct at least 50 low-dose computed tomography (LDCT) scans per year (baseline + follow-up) * Must be able to identify a primary contact person for LCS program operations (e.g., program coordinator, program navigator, program manager, etc.) Staff member inclusion criteria (n \~ 5 at each site/\~40 participants total): * Identified staff member of the LCS program site * \>18 years of age * Must be able to complete study surveys and interviews in English * Willing to provide informed consent Exclusion Criteria: * none
Where this trial is running
Denver, Colorado
- University of Colorado Hospital — Denver, Colorado, United States (Recruiting)
Study contacts
- Principal investigator: Jamie Studts, PhD — University of Colorado, Denver
- Study coordinator: Kaitlyn Hoover
- Email: kaitlyn.hoover@cuanschutz.edu
- Phone: 7702387144
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.